Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides

AIDS

Volumn 20, Issue 9, 2006, Pages 1237-1245

  Fletcher, Patricia S ^a   Elliott, Julie ^b   Grivel, Jean Charles ^c   Margolis, Leonid ^c   Anton, Peter ^b   McGowan, Ian ^b   Shattock, Robin J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anal intercourse; Explants; Gut associated lymphoid tissue; HIV prevention; Rectal mucosa; Sexual transmission; Topical microbicides

Indexed keywords

ANTIGEN P24; ANTIVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; DAPIVIRINE; DEXTRIN SULFATE; HLA DR ANTIGEN; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; PRO 2000; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; RECTUM; RECTUM MUCOSA; SIGMOID; T LYMPHOCYTE; TISSUE CULTURE; TISSUE STRUCTURE; VIRUS INHIBITION; VIRUS TRANSMISSION;

ADMINISTRATION, TOPICAL; ANTIVIRAL AGENTS; CELL SEPARATION; COLON; DRUG EVALUATION; FLOW CYTOMETRY; GELS; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES; PHENOTYPE; RECTUM; TISSUE CULTURE TECHNIQUES; VIRUS REPLICATION;

EID: 33745842280     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000232230.96134.80     Document Type: Article

References (30)

1. Joint UN Programme on HIV/AIDS. AIDS epidemic update. Geneva: UNAIDS; 2004.
2. Macdonald N, Dougan S, McGarrigle CA, Baster K, Rice BD, Evans BG, Fenton KA. Recent trends in diagnoses of HIV and other sexually transmitted infections in England and Wales among men who have sex with men. Sex Transm Infect 2004; 80:492-497.
3. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
4. Misegades L, Page-Shafer K, Halperin D, McFarland W. Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? AIDS 2001; 15:534-535.
5. Halperin D, Shiboski S, Palefsky J, Padian NS. High levels of HIV-1 infection from anal intercourse: a neglected risk factor in heterosexual AIDS prevention. In: XIVth International AIDS Conference. 7-12 July, Barcelona, 2002 [Abstract ThPeC7438].
6. Lapenta C, Boirivant M, Marini M, Santini SM, Logozzi M, Viora M, et al. Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur J Immunol 1999; 29:1202-1208.
7. Poles MA, Elliott J, Taing P, Anton PA, Chen IS. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol 2001; 75:8390-8399.
8. Anton PA, Elliott J, Poles MA, McGowan IM, Matud J, Hultin LE, et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.. AIDS 2000; 14:1761-1765.
9. Richardson BA, Lavreys L, Martin HL Jr, Stevens CE, Ngugi E, Mandaliya K, et al. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis 2001; 28:394-400.
10. Phillips DM, Zacharopoulos VR. Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice. Contraception 1998; 57:341-348.
11. Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA. Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception 2004; 70:107-110.
12. Sudol KM, Phillips DM. Relative safety of sexual lubricants for rectal intercourse. Sex Transm Dis 2004; 31:346-349.
13. D'Cruz OJ, Waurzyniak B, Uckun FM. Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats. Antimicrob Agents Chemother 2004; 48:1082-1088.
14. Patton DL, Cosgrove Sweeney YT, Rabe LK, Hillier SL. Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model. Sex Transm Dis 2002; 29:581-587.
15. Patton DL, Sweeney YC, Cummings PK, Meyn L, Rabe LK, Hillier SL. Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model. Sex Transm Dis 2004; 31:290-296.
16. Tsai CC, Emau P, Jiang Y, Tian B, Morton WR, Gustafson KR, Boyd MR. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res Hum Retroviruses 2003; 19:535-541.
17. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, Shattock RJ. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74:5577-5586.
18. Gupta P, Collins KB, Ratner D, Watkins S, Naus GJ, Landers DV, Patterson BK. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 2002; 76:9868-9876.
19. Collins KB, Patterson BK, Naus GJ, Landers DV, Gupta P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med 2000; 6:475-479.
20. Hu Q, Frank I, Williams V, Santos JJ, Watts P, Griffin GE, et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 2004; 199:1065-1075.
21. Zussman A, Lara L, Lara HH, Bentwich Z, Borkow G. Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781. AIDS 2003; 17: 653-661.
22. Shacklett BL, Yang O, Hausner MA, Elliott J, Hultin L, Price C, et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods 2003; 279: 17-31.
23. Potts B. Mini reverse transcriptase (RT) assay. In: Aldovini A, Walker BD, editors. Techniques in HIV research. New York/ London: Stockton Press/MacMillan Publishers; 1990.
24. Ito Y, Grivel JC, Margolis L. Real-time PCR assay of individual human immunodeficiency virus type 1 variants in coinfected human lymphoid tissues. J Clin Microbiol 2003; 41:2126-2131.
25. Grivel JC, Margolis LB. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 1999; 5:344-346.
26. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431.
27. Grim SA, Romanelli F. Tenofovir disoproxil fumarate. Ann Pharmacother 2003; 37:849-859.
28. Watts P, Wallace G, Mahmood N, Harman S, Romano J, Shattock RJ. UC781 blocks localised infection and cell dissemination pathways within human cervical tissue. In: Microbicides 2004. London, UK, 2004.
29. Harman S, Watts P, Van Roey J, Griffin GE, Shattock RJ. TMC120 blocks HIV-1 infection in cellular and human cervical tissue models. In: Microbicides 2004. London, UK, 2004.
30. Abner SR, Guenthner PC, Guarner J, Hancock KA, Cummins JE Jr, Fink A, et al. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis 2005; 192:1545-1556.